Empower Clinics sees Q3 revenue nearly triple thanks to COVID-19 testing,higher MediSure sales

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has posted sharply higher revenue of $1,573,809 for the third quarter, a 288% jump from the previous year thanks to the launch of its COVID-19 testing clinics for cruise ship passengers in Vancouver, Canada, and increased sales from MediSure. Revenue from Diagnostics and Technology, which includes the sale of MediSure products and COVID-19 testing, amounted to $1,289,808, compared to $160,955 in the same period a year earlier. COVID-19 testing...

read more

Empower Clinics sees 288% year over year growth in revenue as company releases Q3 numbers

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to share news the company has announced positive 3rd Quarter financial numbers that showed a 288% increase year over year. McAuley saying total revenue was 1,573,809 for Q3 2022 compared to revenues of $405,707 for Q3 2021. The big increase was due in part to the launch of the company’s COVID-19 testing clinics for cruise ship passengers and increased sales from MediSure.

read more

Empower Clinics Reports Q3 2022 Results

288% year over year increase in revenue in Q3 2022 VANCOUVER, BC / ACCESSWIRE / November 28, 2022 / EMPOWER CLINICS INC (CSE:EPW)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory - announced today it has filed its unaudited condensed interim consolidated financial statements and related Management's...

read more